Summit Therapeutics
SMMT
#1547
Rank
$13.38 B
Marketcap
$17.26
Share price
-3.79%
Change (1 day)
-13.22%
Change (1 year)

Summit Therapeutics (SMMT) - Net assets

Net assets on the balance sheet as of December 2025 : $0.65 Billion USD

According to Summit Therapeutics 's latest financial reports the company has $0.65 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Summit Therapeutics - Net assets on balance sheet (from 2014 to 2020)

Net assets by year

Year Net assets Change
2025-12-31$$0.65 B69.48%
2024-12-31$$0.38 B400.37%
2023-12-31$$77.69 M-38.66%
2022-12-31$$0.12 B52.07%
2021-12-31$$83.28 M4.82%
2020-12-31$$79.45 M
2019-01-31$$55.78 M-1350.46%
2018-01-31$-$4.47 Million-18.25%
2017-01-31$-$5.46 Million-123.83%
2016-01-31$$22.9 M-33.06%
2015-01-31$$34.21 M335.55%
2014-01-31$$7.85 M10.42%
2013-01-31$$7.11 M19.87%
2012-01-31$$5.93 M-35.58%
2011-01-31$$9.21 M-56.48%
2010-01-31$$21.17 M20.22%
2009-01-31$$17.61 M-83.64%
2008-01-31$$0.10 B36.69%
2007-01-31$$78.75 M89.43%
2006-01-31$$41.57 M-16.82%
2005-01-31$$49.98 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sarepta Therapeutics
SRPT
$1.14 B 73.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
$0.22 B-66.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
$87.77 M-86.68%๐Ÿ‡บ๐Ÿ‡ธ USA